SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-011747
Filing Date
2022-06-16
Accepted
2022-06-16 16:14:08
Documents
13
Period of Report
2022-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rcus-20220614.htm   iXBRL 8-K 82158
2 NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM rcus-ex10_1.htm EX-10.1 57157
  Complete submission text file 0000950170-22-011747.txt   258294

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20220614_lab.xml EX-101.LAB 12798
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20220614_pre.xml EX-101.PRE 9445
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20220614.xsd EX-101.SCH 2457
7 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20220614_htm.xml XML 4523
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 221020728
SIC: 2834 Pharmaceutical Preparations